| Literature DB >> 30338841 |
Izabela Nabiałek-Trojanowska1, Ewa Lewicka2, Anna Wrona3, Anna M Kaleta2, Zuzanna Lewicka-Potocka4, Grzegorz Raczak2, Rafał Dziadziuszko3.
Abstract
Over the past decades, effective cancer therapies have resulted in a significant improvement in the survival rates for a number of cancers and an increase in the number of cancer survivors. Radiation therapy is widely used in the treatment of cancer, and it can induce various cardiotoxicities that differ considerably from chemotherapy-induced cardiotoxicity. They occur primarily as late radiation-induced complications, several years from the end of anticancer treatment and present as coronary artery disease, heart failure, pericardial disease, valvular heart disease and arrhythmias. Patients who recovered from cancer disease suffer from cardiac complications of anticancer treatment, it affects the quality of their lives and life expectancy, especially if the diagnosis is delayed. These patients may present distinct symptoms of cardiac injury, resulting from radiation-induced neurotoxicity and altered pain perception, which makes diagnosis difficult. This review highlights the need for a screening programme for patients who have undergone radiation therapy and which will subsequently have a potentially profound impact on morbidity and mortality.Entities:
Keywords: cardiotoxicity; ionizing radiation; neoplasms; radiation injuries; radiotherapy
Year: 2018 PMID: 30338841 PMCID: PMC8079093 DOI: 10.5603/CJ.a2018.0120
Source DB: PubMed Journal: Cardiol J ISSN: 1898-018X Impact factor: 2.737